AMS X

Carbon Acquires 3D Printing Software Startup ParaMatters

Formnext
IMTS

Share this Article

Carbon, the Silicon Valley-based manufacturer of additive manufacturing (AM) platforms, announced its acquisition of ParaMatters, a software as a services (SaaS) company providing solutions for the 3d printing sector. Carbon makes a full range of products — including software — for its line of Digital Light Synthesis (DLS) polymer printers.

ParaMatters and 3D Printing Design

ParaMatters, also based in Silicon Valley, is known for creating CogniCAD, one of the first widely available generative design and topology optimization programs for AM. Increasingly, generative design and topology optimization have been seen as indispensable tools in the effort to achieve true end-to-end automation in the AM sector.

In a press release announcing the acquisition, co-founder of Carbon, Phil DeSimone, commented, “Many design tools of yesterday are not optimized to take advantage of industry innovations, including advanced 3D printing materials and manufacturing processes. Both Carbon and ParaMatters have shared the same vision to provide modern tools to ensure product development teams can create better products in less time.” Robert Yusin, ParaMatters’ chairman and CEO, added, “The ability to expand our offering as a part of Carbon’s idea-to-production platform will enable our customers to design and produce better products.”

Software is Carbon’s Backbone

As Craig Carlson, the company’s chief technology officer (CTO), also noted in the press release, Carbon sees software as its “backbone”. Last year, the company made its Design Engine software available to the general public.

Given that adidas uses Carbon platforms for its printed midsoles, the latter company is arguably one of the parties most responsible for popularizing the lattice-structure designs characteristic of advanced manufacturing techniques. Beyond aesthetic reasons, the complex geometries involved are necessary for reducing material usage and light-weighting parts. Generative design essentially means that AI is used to achieve those designs as quickly as possible, sometimes cutting the time required for design from weeks to hours.

The increased significance, to the sector as a whole, of using design software specifically designed for AM, means this will be a particularly interesting acquisition to keep track of, once the two companies have had some time to mesh. Whether or not Carbon turns out to be one of them, there does seem to be a certain amount of logic to the idea of OEMs that place an emphasis on software seeing lasting success. If nothing else, Carbon can be seen as a good bellwether for gauging how valid a business strategy this truly currently is.



Share this Article


Recent News

Zaha Hadid Architects Print 6M Model with WASP’s Robotic Arm Solutions

The New Dental Lab: “Three Technicians Can Handle a Hundred Arches,” Says Digital Dentistry Expert Josh Jakson



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Featured

Additive Manufacturing at a Crossroads 

Additive manufacturing is at a crossroads. Simultaneously, we find ourselves between certain very different modalities, applications, and industries. Rather than being able to explore them all, companies will now have...

After 17 Years at 3D Systems, Katie Weimer Is Betting on Regenerative Breast Tissue

After spending 17 years helping build healthcare applications at 3D Systems and its predecessor Medical Modeling, Katie Weimer wasn’t planning to launch a startup. But when a regenerative breast tissue...

Why Elegoo Chose Emoji® to Introduce More People to 3D Printing

When Elegoo unveiled the world’s first officially licensed emoji®-themed 3D printer, it wasn’t just launching another version of an existing machine. The company was testing a much bigger idea by...

The Longevity Economy Needs a Factory

Longevity has become one of the biggest stories in healthcare. Every week seems to add a new announcement about an anti-aging therapy, an AI-powered drug discovery platform, or a startup...